YouTube Facebook LinkedIn Google+ Twitter Xingrss  

ChIP-on-chip Platform


Nov 15, 2005 | Coupling chromatin immunoprecipitation with a glass slide is what Agilent Technologies has launched as its ChIP-on-chip platform, enabling researchers to analyze activity at regulatory regions of genomes. Also called location analysis, this platform provides insight into key mechanisms of embryonic stem cells and illnesses, such as cancer, cardiovascular disease, and central nervous system disorders. The company says emerging applications, coupled with the ability to design and print microarrays containing up-to-date content, are the foundation of its genomics program. Agilent plans to offer a complete solution for location analysis that includes reagents, a microarray portfolio, and data analysis software.

Vendor: Agilent Technologies

Product: ChIP-on-chip microarray platform

Availability: Now

For more information: www.agilent.com

 

View Next Related Story
Click here to login and leave a comment.  

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1


For reprints and/or copyright permission, please contact  Terry Manning, 781.972.1349 , tmanning@healthtech.com.